Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 6, 2003, Pages 987-992

  Li, Jian ^a,d   Coulthard, Kingsley ^a,b   Milne, Robert ^a   Nation, Roger L ^a,d   Conway, Steven ^c   Peckham, Daniel ^c   Etherington, Christine ^c   Turnidge, John ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c SEACROFT HOSPITAL   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Colistin; HPLC; Pharmacodynamics; Pseudomonas

Indexed keywords

AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIMETHATE; COLISTIN; COLO MYCIN; FLUCLOXACILLIN; FUSIDIC ACID; MEROPENEM; METRONIDAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NEUROTOXICITY; PSEUDOMONAS AERUGINOSA; STEADY STATE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLISTIN; CYSTIC FIBROSIS; DRUG STABILITY; FEMALE; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED;

EID: 0348149151     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg468     Document Type: Article

References (30)

1. Hancock, R. E. & Speert, D. P. (2000). Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resistance Update 3, 247-55.
2. Waterer, G. W. & Wunderink, R. G. (2001). Increasing threat of Gram-negative bacteria. Critical Care Medicine 29, N75-81.
3. Tatterson, L. E., Poschet, J. F., Firoved, A. et al. (2001). CFTR and pseudomonas infections in cystic fibrosis. Frontiers in Bioscience 6, D890-7.
4. Davis, P. B., Drumm, M. & Konstan, M. W. (1996). Cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 154, 1229-56.
5. FitzSimmons, S. C. (1993). The changing epidemiology of cystic fibrosis. Journal of Pediatrics 122, 1-9.
6. Goodwin, N. J. (1970). Colistin and sodium colistimethate. Medical Clinics of North America 54, 1267-76.
7. Beringer, P. (2001). The clinical use of colistin in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine 7, 434-40.
8. Conway, S. P., Etherington, C., Munday, J. et al. (2000). Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. Annals of Pharmacotherapy 34, 1238-42.
9. Evans, M. E., Feola, D. J. & Rapp, R. P. (1999). Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Annals of Pharmacotherapy 33, 960-7.
10. Littlewood, J. M., Koch, C., Lambert, P. A. et al. (2000). A ten year review of Colomycin. Respiratory Medicine 94, 632-40.
11. Catchpole, C. R., Andrews, J. M., Brenwald, N. et al. (1997). A reassessment of the in-vitro activity of colistin sulphomethate sodium. Journal of Antimicrobial Chemotherapy 39, 255-60.
12. Hancock, R. E. (1997). Peptide antibiotics. Lancet 349, 418-22.
13. Orwa, J. A., Van Gerven, A., Roets, E. et al. (2000). Development and validation of a liquid chromatography method for analysis of colistin sulphate. Chromatographia 51, 433-6.
14. Orwa, J. A., Govaerts, C., Busson, R. et al. (2001). Isolation and structural characterization of colistin components. Journal of Antibiotics 54, 595-9.
15. Beveridge, E. G. & Martin, A. J. (1967). Sodium sulphomethyl derivatives of polymyxins. British Journal of Pharmacology and Chemotherapy 29, 125-35.
16. Barnett, M., Bushby, S. R. & Wilkinson, S. (1964). Sodium sulphomethyl derivatives of polymyxins. British Journal of Pharmacology 23, 552-74.
17. Schwartz, B. S., Warren, M. R., Barkley, F. A. et al. (1960). Microbiological and pharmacological studies of colistin sulphate and sodium colistin methanesulfonate. Antibiotics Annual 1959-1960, 41-60.
18. Li, J., Turnidge, J., Milne, R. et al. (2001). In vitro pharmaco-dynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 45, 781-5.
19. Conway, S. P., Pond, M. N., Watson, A. et al. (11997). Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 52, 987-93.
20. Reed, M. D., Stern, R. C., O'Riordan, M. A. et al. (2001). The pharmacokinetics of colistin in patients with cystic fibrosis. Journal of Clinical Pharmacology 41, 645-54.
21. Mackay, D. N. & Kaye, D. (1964). Serum concentrations of colistin in patients with normal and impaired renal function. New England Journal of Medicine 270, 394-7.
22. Froman, J., Gross, L. & Curatola, S. (1970). Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals. Journal of Urology 103, 210-4.
23. Li, J., Milne, R. W., Nation, R. L. et al. (2003). Stability of colistin and colistin methanesulfonate in aqueous media and plasma studied by high-performance liquid chromatography. Antimicrobial Agents and Chemotherapy 47, 1364-70.
24. Li, J., Milne, R. W., Nation, R. L. et al. (2001). A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications 761, 167-75.
25. Li, J., Milne, R. W., Nation, R. L. et al. (2002). Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography. Antimicrobial Agents and Chemotherapy 46, 3304-7.
26. Oliver, A., Canton, R., Campo, P. et al. (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-4.
27. Le Brun, P. P. H., de Graaf, A. I. & Vinks, A. (2000). High-performance liquid chromatographic method for the determination of colistin in serum. Therapeutic Drug Monitoring 22, 589-93.
28. Decolin, D., Leroy, P., Nicolas, A. et al. (1997). Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues. Journal of Chromatographic Science 35, 557-64.
29. Koch-Weser, J., Sidel, V. W., Federman, E. B. et al. (1970). Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Annals of Internal Medicine 72, 857-68.
30. Ledson, M. J., Gallagher, M. J., Cowperthwaite, C. et al. (1998). Four years' experience of intravenous colomycin in an adult cystic fibrosis unit. European Respiratory Journal 12, 592-4.